Dr. Emanuel Petricoin III

 

Professor
  Email: epetrico@gmu.edu
  Website: http://www.gmu.edu/departments/lifesciences/proteomics/petricoin.htm

 

Work Phone: 703-993-8646
  Fax: 703-993-4288
  Office: 181A Discovery Hall
 
BioSketch:

 
Academic Background:

Petricoin holds a doctorate in microbiology from the University of Maryland at College Park
 

Research Interests:

Together with Dr. Lance Liotta, he has formed the Center for Applied Proteomics and Molecular Medicine. The Center has formed a unique partnership between George Mason and Inova Health System. George Mason University-Inova Health System Translational Research Centers is a joint initiative to coordinate multiple programs to implement proteomics, nanotechnology, and genomics research in cancer, metabolic syndrome, cardiopulmonary diseases, and neurodegenerative and liver diseases. This initiative comprises the research efforts of three shared centers: the Center for Applied Proteomics and Molecular Medicine; the Center for Biomedical Genomics; and the Center for the Study of Genomics of Liver Diseases. Inova and George Mason have combined efforts to recruit internationally renowned scientists, such as Lance Liotta and Emanuel Petricoin III, to work closely with clinical investigators from Inova.

Recent Publications
 
An investigation into the human serum
M Zhou  D Lucas  K Chan  H Issaq  E Petricoin III  L Liotta  T Veenstra  T Conrads           
Electrophoresis  2004  25   1289
SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML
D Ornstein  W Rayford  V Fusaro  T Conrads  S Ross  B Hitt  W Wiggins  T Veenstra  L Liotta  E Petricoin III       
J Urol.  2004  172   1302
Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation
R Krieg  R Knuechel  E Schiffmann  L Liotta  E Petricoin III  P Herrmann              
Proteomics  2004  4   2789
Profiling of normal human leg lymph proteins using the 2-D electrophoresis and SELDI-TOF mass spectrophotometry approach
B Interewicz  W Olszewski  L Leak  E Petricoin III  L Liotta               
Lymphology  2004  37   65
Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.
E Petricoin III  D Ornstein  L Liotta                   
Urol Oncol  2004  22   322
 
 

 

 

Copyright © 2005 Life Science & GMU | Webmaster | College of Arts and Sciences | GMU | Last update: April 14, 2005